Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02136498 · ClinicalTrials.gov registry record · NA
My Mobile Advice Program: A Randomized Pilot Feasibility Study
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT02136498: Completed NA study, sponsored by Kaiser Permanente.
NCT02136498 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02136498, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to evaluate the acceptability and feasibility of the proposed smoking cessation intervention (called MyMAP or My Mobile Advice Program).
Primary Outcome
Self-report of no-smoking, even a puff during the last 7 days.
Interventions
- DRUG Varenicline
- BEHAVIORAL Cognitive-behavioral self-help
- BEHAVIORAL MyMAP (My Mobile Advice Program)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-02 |
| Phase | NA |
What the finished NCT02136498 record still lists
NCT02136498 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 3 interventions - of which Varenicline is the first listed.
NCT02136498 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02136498 about?
NCT02136498 is a clinical study titled "My Mobile Advice Program: A Randomized Pilot Feasibility Study". The purpose of this pilot study is to evaluate the acceptability and feasibility of the proposed smoking cessation intervention (called MyMAP or My Mobile Advice Program).
What is the current status of trial NCT02136498?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2014-10. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02136498?
The interventions under investigation include: Varenicline (DRUG), Cognitive-behavioral self-help (BEHAVIORAL), MyMAP (My Mobile Advice Program) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02136498?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02136498's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia